Polar Asset Management Partners Inc. Bristol Myers Squibb CO Call Options Transaction History

Polar Asset Management Partners Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $2.71 Million - $3.24 Million	-44,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $2.36 Million - $2.75 Million	44,000 New	44,000 $2.74 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $669,300 - $740,100	-15,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $676,800 - $807,000	15,000 New	15,000 $716,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.